The Danish Competition Authority issues a study on excessive pricing in pharmaceutical markets

Excessive Pricing in Pharmaceutical Markets* Intervention against possible exploitative and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Danish Competition Authority, The Danish Competition Authority issues a study on excessive pricing in pharmaceutical markets, 28 February 2019, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 89767

Visites 420

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues